It is inhibited e.g., by methylphenidate and amphetamines as treatment for ADHD and depression19,127, and changes in DAT expression have been reported in schizophrenia, ADHD, and Parkinson’s128. This evidence concerns the gene SLC6A3 and attention deficit-hyperactivity disorder.